Topic: Slides | M320- Cancer Biology- Spring 2026

Calendar

Section outline

- Select activity 3.2.26- Pablo Sanchez Vela- Introduction to Cancer Biology
  
  3.2.26- Pablo Sanchez Vela- Introduction to Cancer Biology File
- Select activity 3.5.26- Asmin Tulpule- Oncogenes
  
  3.5.26- Asmin Tulpule- Oncogenes File
- Select activity 3.16.26- Scott Lowe- p53 and Tumor suppression
  
  3.16.26- Scott Lowe- p53 and Tumor suppression File
- Select activity 3.18.26- Tuomas Tammela- Cancer Evolution
  
  3.18.26- Tuomas Tammela- Cancer Evolution File
- Select activity 3.20.26- Adam Widman- Digital Oncology
  
  3.20.26- Adam Widman- Digital Oncology File
- Select activity 3.23.26- Jian Carrot-Zhang- Genomic Analysis of Cancer
  
  3.23.26- Jian Carrot-Zhang- Genomic Analysis of Cancer File
- Select activity 3.25.26- Karuna Ganesh- Colon Cancer
  
  3.25.26- Karuna Ganesh- Colon Cancer File
- Select activity 3.27.26- Pablo Sanchez Vela- Interactive Session/Group Project
  
  3.27.26- Pablo Sanchez Vela- Interactive Session/Group Project File
- Select activity 3.30.26- Andrew Intlekofer- Lymphoma/IDH Inhibitors
  
  3.30.26- Andrew Intlekofer- Lymphoma/IDH Inhibitors File
- Select activity 3.31.26- Andrew Intlekofer- Cancer Metabolism
  
  3.31.26- Andrew Intlekofer- Cancer Metabolism File
- Select activity 4.1.26- Ross Levine- Genetic Drivers of Hematopoietic Malignancies
  
  4.1.26- Ross Levine- Genetic Drivers of Hematopoietic Malignancies File
- Select activity 4.2.26- Ivan Maillard- Notch signaling – from physiology to cancer biology (Part 1)
  
  4.2.26- Ivan Maillard- Notch signaling – from physiology to cancer biology (Part 1) File
- Select activity 4.2.26- Ivan Maillard- New insights into the role of Notch signaling in T and B cell immunity (Part 2)
  
  4.2.26- Ivan Maillard- New insights into the role of Notch signaling in T and B cell immunity (Part 2) File
- Select activity 4.2.26- Ivan Maillard- A primer to early T cell development for cancer biologists (Part 3)
  
  4.2.26- Ivan Maillard- A primer to early T cell development for cancer biologists (Part 3) File
- Select activity 4.6.26- Kayvan Keshari- Leveraging Cancer Metabolism
  
  4.6.26- Kayvan Keshari- Leveraging Cancer Metabolism File
- Select activity 4.7.26- Mara Sherman- Pancreatic Cancer
  
  4.7.26- Mara Sherman- Pancreatic Cancer File
- Select activity 4.13.26- Adrienne Boire- Metastasis to CNS
  
  4.13.26- Adrienne Boire- Metastasis to CNS File
- Select activity 4.20.26- Kathryn Taylor- Neuron-Cancer Interactions
  
  4.20.26- Kathryn Taylor- Neuron-Cancer Interactions File
- Select activity 4.23.26- Kojo Elenitoba- Johnson- Cancer Biomarkers and Therapeutic Targets from Functional Proteogenomics
  
  4.23.26- Kojo Elenitoba- Johnson- Cancer Biomarkers and Therapeutic Targets from Functional Proteogenomics File
- Select activity 4.24.26- Nai-Kong Cheung- Therapeutic Antibodies Pediatric Cancers
  
  4.24.26- Nai-Kong Cheung- Therapeutic Antibodies Pediatric Cancers File
- Select activity 4.27.26- Sarat Chandarlapaty- Breast Cancer
  
  4.27.26- Sarat Chandarlapaty- Breast Cancer File
- Select activity 4.30.26- Ping Chi- Epigenetic Control of Oncogene Signaling in Sarcoma
  
  4.30.26- Ping Chi- Epigenetic Control of Oncogene Signaling in Sarcoma File